Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KMDA stock hub

Kamada Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KMDAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
496.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KMDA
In the news

Latest news · KMDA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16
P25 12.3P50 18.4P75 33.1
Trailing P/E24.6
P25 14.9P50 23.2P75 38.5
ROE7.6
P25 -105.6P50 -46.5P75 -3.1
ROIC11
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KMDA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
261
Groups with data
11
Currency
USD
Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001567529
Company name
Kamada Ltd.
Country
Israel
Country code
US
Cusip
M6240T109
Employees
462
Employees Change
42%
Employees Change Percent
10
Enterprise value
$426M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Drug Manufacturers - Specialty & Generic
Isin
IL0010941198
Last refreshed
2026-05-10
Market cap
$496.3M
Market cap category
Small-Cap
Price
$8.54
Price currency
USD
Rev Per Employee
390,606.06x
Sector
Healthcare
Sic
2834
Symbol
KMDA
Website
https://www.kamada.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

16
MetricValue
Earnings Yield
4.07%
EV Earnings
21.09x
EV Sales Forward
2.07x
EV/EBIT
16.24x
EV/EBITDA
10.78x
EV/FCF
27.23x
EV/Sales
2.36x
FCF yield
3.15%
Forward P/E
15.95x
P/B ratio
1.84x
P/E ratio
24.57x
P/S ratio
2.75x
PE Ratio10 Y
23.06x
PE Ratio3 Y
30.67x
PE Ratio5 Y
30.83x
PS Forward
2.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
14.54%
EBITDA Margin
21.9%
FCF margin
8.67%
Gross margin
42.34%
Gross Profit
$76.4M
Gross Profit Growth
9.2%
Gross Profit Growth Q
-0.38%
Gross Profit Growth3 Y
17.83%
Gross Profit Growth5 Y
9.95%
Net Income
$20.2M
Net Income Growth
39.66%
Net Income Growth Q
-6.46%
Net Income Growth Years
3%
Net Income Growth5 Y
3.34%
Pretax Margin
13%
Profit Margin
11.19%
Profit Per Employee
$43,719
Profitable Years
3
ROA
4.37
Roa5y
2.16
ROCE
7.92
ROE
7.64
Roe5y
2.95
ROIC
11.02
Roic5y
6.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr10y
8.27%
Cagr1y
29.23%
Cagr3y
21.96%
Cagr5y
8.14%
EPS Growth
40
EPS Growth Q
-14.11
EPS Growth Years
3
EPS Growth5 Y
-1.63
FCF Growth
-57.55%
FCF Growth Q
-35.9%
FCF Growth3 Y
-14.24%
FCF Growth5 Y
2.81%
OCF Growth
-46.44%
OCF Growth Q
-27.24%
OCF Growth3 Y
-3.75%
OCF Growth5 Y
5.94%
Revenue Growth
12.12x
Revenue Growth Q
14.54x
Revenue Growth Quarters
8x
Revenue Growth Years
4x
Revenue Growth3 Y
11.74x
Revenue Growth5 Y
6.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
$0.48
Assets
$378.7M
Cash
$75.5M
Current Assets
$193.1M
Current Liabilities
$47.4M
Debt
$11.6M
Debt EBITDA
$0.28
Debt Equity
$0.04
Debt FCF
$0.74
Equity
$269.1M
Interest Coverage
30.36
Liabilities
$109.6M
Long Term Assets
$185.6M
Long Term Liabilities
$62.2M
Net Cash
$63.9M
Net Cash By Market Cap
$12.88
Net Cash Growth
-5.14%
Net Debt EBITDA
$-1.62
Net Debt Equity
$-0.24
Net Debt FCF
$-4.09
Tangible Book Value
$142.7M
Tangible Book Value Per Share
$2.47
WACC
5.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.07
Inventory Turnover
1.27
Net Working Capital
$72.3M
Quick ratio
2.2
Working Capital
$145.7M
Working Capital Turnover
$1.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.91%
Dividend Growth
0%
Dividend Growth Years
1%
Dividend per share
$0.25
Dividend Years
2
Dividend Yield
2.93%
Ex Div Date
2026-03-23
Last Dividend
$0.25
Payout Frequency
Annual
Payout Ratio
71.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
121.29%
1Y total return
29.2%
200-day SMA
7.61
3Y total return
81.42%
50-day SMA
8.47
50-day SMA vs 200-day SMA
50over200
5Y total return
47.89%
All Time High
17.95
All Time High Change
-52.42%
All Time High Date
2014-02-27
All Time Low
3.02
All Time Low Change
182.78%
All Time Low Date
2014-11-25
ATR
0.21
Beta
0.2
Ch YTD
20.96
High
8.55
High52
9.35
High52 Date
2026-02-25
High52ch
-8.66%
Low
8.36
Low52
6.5
Low52 Date
2025-10-07
Low52ch
31.39%
Ma50ch
0.89%
Premarket Change Percent
4.12
Premarket Price
$8.6
Premarket Volume
5,781
Price vs 200-day SMA
12.18%
RSI
58.28
RSI Monthly
65.26
RSI Weekly
59.39
Sharpe ratio
0.81x
Sortino ratio
1.5
Total Return
2.01%
Tr YTD
24.63
Tr1m
3.52%
Tr1w
4.02%
Tr3m
7.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

14
MetricValue
Analyst Count
2
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$0.12
Earnings EPS Estimate Growth
71.43
Earnings Revenue Estimate
124,203,648x
Earnings Revenue Estimate Growth
182.17x
Operating Income
$26.2M
Operating Income Growth
30.83
Operating Income Growth Q
-30.07
Operating Income Growth3 Y
79.55
Operating Income Growth5 Y
6.4
Operating margin
14.54
Price target
$14
Price Target Change
$63.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
10,821,060%
Float Percent
18.76%
Net Borrowing
-972,000
Shares Insiders
4.67%
Shares Institutions
20.32%
Shares Out
57,686,056
Shares Qo Q
0.89%
Shares Yo Y
0.91%
Short Ratio
1.78
Short Shares
0.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

72
MetricValue
Adjusted FCF
$14.8M
Average Volume
40,313.5x
Bv Per Share
4.66
CAPEX
$-9.8M
Ch10y
108.8
Ch1m
3.52
Ch1w
4.02
Ch1y
25.4
Ch3m
4.02
Ch3y
71.18
Ch5y
39.54
Ch6m
28.23
Change
3.39%
Change From Open
0.12
Close
8.26
Days Gap
3.27
Depreciation Amortization
13,279,000
Dollar Volume
332,077.9
Earnings Date
2026-05-13
Earnings Time
bmo
EBIT
$26.2M
EBITDA
$39.5M
EPS
$0.35
F Score
6
FCF
$15.6M
FCF EV Yield
3.67x
FCF Per Share
$0.27
Financing CF
-18,345,000
Fiscal Year End
December
Founded
1,990
Goodwill
30,313,000
Graham Number
6.02456
Graham Upside
-29.54
Income Tax
$3.3M
Investing CF
-9,838,000
Is Primary Listing
0
Is Spac
No
Last Earnings Date
2026-03-11
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-11
Lynch Fair Value
$1.74
Lynch Upside
-79.65
Ma150
7.78
Ma150ch
9.77%
Ma20
8.29
Ma20ch
3.03%
Net CF
-2,966,000
Next Earnings Date
2026-05-13
Open
8.53
Optionable
Yes
P FCF Ratio
31.72
P OCF Ratio
19.47
Payment Date
2026-04-07
Position In Range
94.74
Post Close
8.54
Postmarket Change Percent
0.12
Postmarket Price
$8.55
Ppne
50,267,000
Pre Close
8.26
Price Date
2026-05-08
Price EBITDA
$12.56
Ptbv Ratio
3.48
Relative Volume
0.96x
Revenue
180,460,000x
SBC By Revenue
0.47x
Share Based Comp
845,000
Tax By Revenue
1.81x
Tax Rate
13.93%
Tr6m
32.11%
Volume
38,885
Z Score
3.33
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KMDA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.9%
$0.25 annual per share
Payout ratio
+71.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
+2.0%
Next ex-dividend date: 2026-03-23
Performance

KMDA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+29.2%
S&P 500 1Y: n/a
3Y total return
+81.4%
S&P 500 3Y: n/a
5Y total return
+47.9%
S&P 500 5Y: n/a
10Y total return
+121.3%
S&P 500 10Y: n/a
Ownership

Who owns KMDA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.3%
Float: +18.8% of shares outstanding
Insider ownership
+4.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
1.8 days to cover
Y/Y dilution
+0.9%
Negative means the company is buying back shares.
Technical

KMDA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
58.3
Neutral momentum band
Price vs 200-day MA
+12.2%
50/200-day relationship not available
Beta (5Y)
0.20
Less volatile than the market
Sharpe ratio
0.81
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KMDA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current KMDA stock rating?

Kamada Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full KMDA analysis?

The full report lives at /stocks/KMDA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for KMDA?

The latest report frames KMDA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the KMDA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.